| Trial ID: | L1950 |
| Source ID: | NCT01061060
|
| Associated Drug: |
Prostaglandin I2
|
| Title: |
The Effect of Prostaglandin I2 on the Endothelial Cell Function Disorder in Type 2 Diabetes Mellitus Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Peripheral Microvascular Symptoms
|
| Interventions: |
DRUG: Prostaglandin I2|DRUG: Placebo
|
| Outcome Measures: |
Primary: Symptomatic improvement by Total Symptom Score (TSS), after 8-week treatment | Secondary: Change in endothelial function expressed in the unit of temperature rebound and the extent of its rise, after 8-week treatment|Change in mean rate of blood flow in the toes, after 8-week treatment
|
| Sponsor/Collaborators: |
Sponsor: Yonsei University | Collaborators: Astellas Pharma Korea, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
110
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-01
|
| Completion Date: |
2010-10
|
| Results First Posted: |
|
| Last Update Posted: |
2016-02-15
|
| Locations: |
Seoul, Seodaemun-gu, 120-752, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01061060
|
